Quick Take Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease

Quick Take: Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease

06:00 EDT 17 Mar 2019 | 2 Minute Medicine

Chronic metabolic acidosis is often seen in patients with chronic kidney disease (CKD), and results from an inability to excrete metabolically produced acid. This, in turn, is associated with bone resorption, muscle catabolism, and progression of kidney disease. Veverimer is a non-absorbable medication that removes hydrochloric acid from the gut lumen in order to combat […]
Source: 2 Minute Medicine

More From BioPortfolio on "Quick Take: Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease"